JPRN-UMIN000010196已完成未知
Study of the safety and efficacy of tolvaptan for fluid retention symptoms of right heart failure due to pulmonary hypertension - Tolvaptan for right heart failure due to pulmonary hypertension
Department of Cardiology, Keio University School of Medicine0 个研究点目标入组 40 人开始时间: 2013年3月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Systolic blood pressure is less than or equal to 70mmHg 2) There is a history of hypersensitivity for similar compounds (such as hydrochloride Mozabaputan) components or tolvaptan 3) Anuria 4) A subject is difficult to feel thirst or water intake 5) Hypernatremia 6) There is a possibility that a subject is pregnant or pregnant women 7) Hepatic coma 8) There is a history of hypersensitivity to sulfonamide derivatives 9) Tolvaptan has been administered from admission to registration 10) Acute coronary syndromes 11) Scheduled to perform coronary angioplasty during follow-up period 12) Physicians and other staff have been deemed inappropriate for registration of this study
研究者
相似试验
尚未招募
4 期
A study on the safety and efficasy of tolvaptan for patients with fluid retention after cardiothoracic surgeryPatients received cardiothoracic surgery with congestive heart failure.JPRN-UMIN000011172Osaka city university graduate school of medicine210
招募中
不适用
A study to evaluate effect and safety of Tolvaptan in Nephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor gene.ephrogenic Diabetes Insipidus caused by mutations in the vasopressin type 2 receptor geneJPRN-UMIN000021708Department of Nephrology and Endocrinology, The University of Tokyo Hospital3
已完成
不适用
ongitudinal Efficacy and Safety Study of Tolvaptan on Autosomal Dominant Polycystic Kidney Disease PatientsAutosomal Dominant Polycystic Kidney DiseaseJPRN-UMIN000021267Autosomal Dominant Polycystic Kidney Disease Research Section, Kyorin University, School of Medicine119
招募中
不适用
Efficasy and safety of tolvaptan in patients undergoing peritoneal dialysis with heart failure despite the standard treatment with conventionalJPRN-UMIN000008712Division of Kidney and Hypertension, the Jikei University School of Medicine40
已完成
不适用
Efficacy and safety of tolvaptan on patients with severe chronic kidney disease complicated by congestive heart failuresevere chronic kidney disease complicated by congestive heart failureJPRN-UMIN000029787Department of Nephrology, Nippon Medical School50